Johnson & Johnson
JNJ
#18
Rank
C$811.22 B
Marketcap
C$336.62
Share price
0.44%
Change (1 day)
46.96%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Johnson & Johnson (JNJ) - Cash on Hand

Cash on Hand as of December 2025 : C$27.55 Billion

According to Johnson & Johnson's latest financial reports the company has C$27.55 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Johnson & Johnson - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$27.52 B-21.77%
2024-12-31C$35.18 B15.72%
2023-12-31C$30.40 B0.58%
2022-12-31C$30.23 B-24.94%
2021-12-31C$40.28 B25.44%
2020-12-31C$32.11 B27.48%
2019-12-31C$25.18 B-6.07%
2018-12-31C$26.81 B16.58%
2017-12-31C$23.00 B-59.15%
2016-12-31C$56.31 B5.79%
2015-12-31C$53.23 B38.64%
2014-12-31C$38.39 B23.51%
2013-12-31C$31.08 B48.25%
2012-12-31C$20.97 B-36.1%
2011-12-31C$32.81 B18.7%
2010-12-31C$27.64 B35.27%
2009-12-31C$20.43 B31.23%
2008-12-31C$15.57 B67.6%
2007-12-31C$9.29 B95.43%
2006-12-31C$4.75 B-74.69%
2005-12-31C$18.78 B21.41%
2004-12-31C$15.47 B25.27%
2003-12-31C$12.35 B4.64%
2002-12-31C$11.80 B-7.04%
2001-12-31C$12.69 B25.45%
2000-12-31C$10.12 B80.95%
1999-12-31C$5.59 B30.75%
1998-12-31C$4.27 B8.78%
1997-12-31C$3.93 B42.8%
1996-12-31C$2.75 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
C$15.80 B-42.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$20.53 B-25.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.59 B-61.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$11.41 B-58.58%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$9.96 B-63.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.32 B-48.01%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
C$10.07 B-63.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
C$5.61 B-79.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$24.96 B-9.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$6.09 B-77.89%๐Ÿ‡ฌ๐Ÿ‡ง UK